Please note ThinkMarkets does not provide CFD services to residents of the US.

Please note ThinkMarkets does not provide CFD services to residents of the US.

Learn To Trade
 
Indicators & Chart Patterns

Deepen your knowledge of technical analysis indicators and hone your skills as a trader.

Find your detailed guides here
Trading Glossary

From beginners to experts, all traders need to know a wide range of technical terms. Let us be your guide.

Learn more
Knowledge Base

No matter your experience level, download our free trading guides and develop your skills.

Learn more
Learn To Trade

Trade smarter: boost your skills with our training resources.

Create a live account
Market Analysis
 
Market News

All the latest market news, with regular insights and analysis from our in-house experts

Learn more
Economic Calendar

Make sure you are ahead of every market move with our constantly updated economic calendar.

Learn more
Technical Analysis

Harness past market data to forecast price direction and anticipate market moves.

Learn more
Live Webinars

Boost your knowledge with our live, interactive webinars delivered by industry experts.

Register now
Special Reports

Engaging, in-depth macroeconomic analysis and expert educational content from our in-house analysts

Learn more
Market Analysis

Harness the market intelligence you need to build your trading strategies.

Create a live account
Partnership
 
Affiliate Programme

Grow your business and get rewarded. Find out more about our Affiliate Programme today.

Learn more
Introducing Broker

ThinkMarkets ensures high levels of client satisfaction with high client retention and conversion rates.

Learn more
Proprietary Trading

Partner with us to build your own prop trading business. Enquire with our account managers today.

Learn more
White Label

We supply everything you need to create your own brand in the Forex industry.

Learn more
Regional Representatives

Partner with ThinkMarkets today to access full consulting services, promotional materials and your own budgets.

Learn more
Refer a friend

Receive $50 for you and your friend when you convert them into an active trader of ThinkMarkets.

Learn more
Partnership

Plug into the next-gen platforms and the trades your clients want.

Partner Portal
About ThinkMarkets
 
Sponsorships

Check out our sponsorships with global institutions and athletes, built on shared values of excellence.

Learn more
About Us

Find out more about ThinkMarkets, an established, multi-award winning global broker you can trust.

Learn more
Careers

Discover a range of rewarding career possibilities across the globe

Apply now
ThinkMarkets News

Keep up to date with our latest company news and announcements

Learn more
Trading Infrastructure

When it comes to the speed we execute your trades, no expense is spared. Find out more.

Learn more
Contact Us

Our multilingual support team is here for you 24/7.

Learn more
About ThinkMarkets

Global presence, local expertise - find out what sets us apart.

Create a live account
Log in Create account

Sentiment remains supported by vaccine news

Fawad Razaqzada Fawad Razaqzada 23/11/2020
Sentiment remains supported by vaccine news Sentiment remains supported by vaccine news
Sentiment remains supported by vaccine news Fawad Razaqzada
Another Monday, another positive vaccine update and thus another cheerful news for bullish investors. Although by midday in London the major European stock indices had given up a good chunk of their earlier gains, they maintained their overall bullish structure, nonetheless. Meanwhile, in FX, the dollar continued to fall – a clear indication that investors were seeking risk rather than haven. This was also evident by rising oil prices.

AstraZeneca-Oxford vaccine

AstraZeneca’s vaccine candidate prevents an average of 70% of coronavirus cases, which is somewhat disappointing when compared with Moderna and Pfizer-BioNtech efficacies rates.

HOWEVER, there are some important differences that needs to be taken into account. This figure is the average between two dosing regimens, with one having a 90% efficacy rate and the other a 62% efficacy rate.

The 90% efficacy rate was achieved when the vaccine was given as a combined half a dose, followed by a full dose a month later. So, in the regard, the result was very similar to the other vaccines with a high efficacy rate. AstraZeneca’s vaccine also has logistical advantages, as it can be stored at normal fridge temperatures, making it scalable and easier to deliver to a much wider demographic. In contrast, the Pfizer-BioNTech and Moderna vaccines need to be stored at much colder temperatures.

What’s more, the AstraZeneca-Oxford vaccine is produced at cost price and not for profit, and will thus cost a lot less than Pfizer and Moderna vaccines, which are made for profit. Given these benefits, the vaccine is likely to be in huge demand from poorer regions of the world.

Long and short of it

The key takeaway point is that we are getting ever closer to hopefully becoming immunised to COVID, which means life can return to more normal levels soon. As such, investors are continuing to shrug off concerns about the ongoing global surge in coronavirus cases and piling back into sectors that had been hurt badly by the pandemic such as travel and leisure. Crude oil prices have also risen as investors hope that with the development of vaccines, there will be a quicker return to normal levels of travel and economic activity.

EU Services PMI underscore extent of lockdown damage

Meanwhile today’s European PMI data revealed some interesting insights, highlighting how the fresh lockdowns have started to hurt the recovery. Everyone was expecting economic data in the services sector to deteriorate in the coming weeks due to the impact of the latest lockdowns and that’s exactly how it has turned out.
 
French (38.0 down from 46.5), German (46.2 down from 49.5) and Eurozone (41.3 from from 46.9) services PMI all fell further into contraction. The U.K. service PMI (45.8, down from 51.4) also fell into contraction, albeit it still managed to beat expectations.
 
As the focus remains on development of vaccines and a potentially sharp recovery starting from around the Christmas period, when lockdowns are expected to be lifted across Europe, the markets hardly responded to the services PMI data. Still, the pound outperformed slightly given that the U.K. data was stronger, although this could also be because of rising Brexit optimism.
 
Surprisingly, UK’s manufacturing PMI easily beat at 55.2 vs 50.2 expected, and compared with a reading of 53.7 previously. Crucially for the euro zone, the German manufacturing PMI also beat at 57.9 vs 56.6 expected, even if it fell from the prior reading of 58.2. However, French manufacturing PMI unexpectedly fell back to contraction, printing 49.1 vs 50.1 expected and 51.3 last.

With stocks rising, watch out for a bullish breakout on the German DAX index from this consolidation pattern:

DAXSource: ThinkMarkets and TradingView.com
Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice. ThinkMarkets will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information.

Related articles:

RDDT soars: here are the levels to watch in c...

By Alejandro Zambrano

26/03/2024

Weekly Market Outlook - 25 MAR to 29 MAR 2024

By

25/03/2024

Weekly Index Dividends

By ThinkMarkets

25/03/2024

Reddit Launches IPO: Can the Struggling Compa...

By Alejandro Zambrano

21/03/2024

Weekly Market Outlook - 18 MAR to 22 MAR 2024

By ThinkMarkets

18/03/2024

Any opinions, news, research, analyses, prices or other information contained on this website is provided as general market commentary and does not constitute investment advice. ThinkMarkets will not accept liability for any loss or damage including, without limitation, to any loss of profit which may arise directly or indirectly from use of or reliance on such information.
Back to top